Picture of Infant Bacterial Therapeutics AB logo

IBT B — Infant Bacterial Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Infant Bacterial Therapeutics Starts Listing On Nasdaq Stockholm Main Market On Sept 10

Aug 30 (Reuters) - Infant Bacterial Therapeutics AB  IBTb.ST :
    * REG-INFANT BACTERIAL THERAPEUTICS HAS BEEN APPROVED FOR LISTING ON THE MAIN MARKET OF
NASDAQ
STOCKHOLM
    * LAST DAY OF TRADING ON NASDAQ FIRST NORTH PREMIER IS SCHEDULED FOR SEPTEMBER 7, 2018
    * FIRST DAY OF TRADING ON NASDAQ STOCKHOLM IS SCHEDULED FOR SEPTEMBER 10, 2018

Source text for Eikon:  ID:nGNE68CxWN 
Further company coverage:  IBTb.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Infant Bacterial Therapeutics AB

See all news